{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:30:34Z","timestamp":1786116634116,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,6]]},"DOI":"10.7759\/cureus.114053","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:35:23Z","timestamp":1786016123000},"source":"Crossref","is-referenced-by-count":0,"title":["Prospective Assessment of Short-Term Response and Acute Toxicity With Accelerated Fractionation Radiotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer"],"prefix":"10.7759","author":[{"given":"Pranabandhu","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GV","family":"Deepthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praneetha","family":"Chevireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala Venkat","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivasa Rao","family":"Bonala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel RL","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025, 75:10-45. 10.3322\/caac.21871","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.11.978-JHA90001-4-1","article-title":"Cervical cancer","volume":"281","author":"Stephenson J","year":"1999","unstructured":"Stephenson J. Cervical cancer. JAMA. 1999, 281:978. 10.1001\/jama.281.11.978-JHA90001-4-1","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose PG","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB, et al.. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999, 340:1144-53. 10.1056\/NEJM199904153401502","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05965-7","article-title":"Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis","volume":"358","author":"Green JA","year":"2001","unstructured":"Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001, 358:781-6. 10.1016\/S0140-6736(01)05965-7","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.08.038","article-title":"Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries","volume":"70","author":"Ohno T","year":"2008","unstructured":"Ohno T, Nakano T, Kato S, et al.. Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries. Int J Radiat Oncol Biol Phys. 2008, 70:1522-9. 10.1016\/j.ijrobp.2007.08.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00220-S","article-title":"Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy","volume":"32","author":"Perez CA","year":"1995","unstructured":"Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 1995, 32:1275-88. 10.1016\/0360-3016(95)00220-S","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00635-X","article-title":"The adverse effect of treatment prolongation in cervical carcinoma","volume":"32","author":"Petereit DG","year":"1995","unstructured":"Petereit DG, Sarkaria JN, Chappell R, et al.. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 1995, 32:1301-7. 10.1016\/0360-3016(94)00635-X","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.10.075","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer","volume":"79","author":"Lim K","year":"2011","unstructured":"Lim K, Small W Jr, Portelance L, et al.. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011, 79:348-55. 10.1016\/j.ijrobp.2009.10.075","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay HA","year":"2012","unstructured":"Gay HA, Barthold HJ, O'Meara E, et al.. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012, 83:e353-62. 10.1016\/j.ijrobp.2012.01.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.05.062","article-title":"Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy","volume":"63","author":"Taylor A","year":"2005","unstructured":"Taylor A, Rockall AG, Reznek RH, Powell ME. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005, 63:1604-12. 10.1016\/j.ijrobp.2005.05.062","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref13","article-title":"Common Terminology Criteria for Adverse Events (CTCAE)","year":"2017","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). National Cancer Institute, Bethesda, MD; 2017."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox JD","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995, 31:1341-6. 10.1016\/0360-3016(95)00060-C","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.148676","article-title":"Can pure accelerated radiotherapy given as six fractions weekly be an option in locally advanced carcinoma cervix: results of a prospective randomized phase III trial","volume":"12","author":"Sharma M","year":"2016","unstructured":"Sharma M, Revannasiddaiah S, Gupta M, Seam RK, Gupta MK, Rastogi M. Can pure accelerated radiotherapy given as six fractions weekly be an option in locally advanced carcinoma cervix: results of a prospective randomized phase III trial. J Cancer Res Ther. 2016, 12:103-8. 10.4103\/0973-1482.148676","journal-title":"J Cancer Res Ther"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.9790\/0853-131250411","article-title":"Concomitant chemoradiation versus accelerated radiotherapy in selected cases of locally advanced carcinoma cervix-a prospective study","volume":"13","author":"Basu A","year":"2014","unstructured":"Basu A, Ghosh K, Basu A. Concomitant chemoradiation versus accelerated radiotherapy in selected cases of locally advanced carcinoma cervix-a prospective study. IOSR JDMS. 2014, 13:4-11.","journal-title":"IOSR JDMS"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-012-0250-9","article-title":"Pure accelerated radiation versus concomitant chemoradiation in selected cases of locally advanced carcinoma cervix: a prospective study","volume":"62","author":"Roy C","year":"2012","unstructured":"Roy C, Bhanja Choudhury K, Pal M, Chowdhury K, Ghosh A. Pure accelerated radiation versus concomitant chemoradiation in selected cases of locally advanced carcinoma cervix: a prospective study. J Obstet Gynaecol India. 2012, 62:679-86. 10.1007\/s13224-012-0250-9","journal-title":"J Obstet Gynaecol India"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2022.v15i8.45120","article-title":"Toxicity and treatment outcome of accelerated fractionation radiotherapy versus conventional fractionated concomitant chemoradiation in locally advanced cervical carcinoma: a prospective study","volume":"15","author":"Daripa SH","year":"2022","unstructured":"Daripa SH, Banerjee SA, Sadhya AP, Bera AN. Toxicity and treatment outcome of accelerated fractionation radiotherapy versus conventional fractionated concomitant chemoradiation in locally advanced cervical carcinoma: a prospective study. Asian J Pharm Clin Res. 2022, 15:127-31. 10.22159\/ajpcr.2022.v15i8.45120","journal-title":"Asian J Pharm Clin Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65154","article-title":"Accelerated radiotherapy alone versus chemoradiation in locally advanced carcinoma cervix: long-term outcomes","volume":"16","author":"Kushwaha VS","year":"2024","unstructured":"Kushwaha VS, Srivastava K, Kumar S, Barik SK. Accelerated radiotherapy alone versus chemoradiation in locally advanced carcinoma cervix: long-term outcomes. Cureus. 2024, 16:e65154. 10.7759\/cureus.65154","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/516167-prospective-assessment-of-short-term-response-and-acute-toxicity-with-accelerated-fractionation-radiotherapy-versus-concurrent-chemoradiotherapy-in-locally-advanced-cervical-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:35:23Z","timestamp":1786016123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/516167-prospective-assessment-of-short-term-response-and-acute-toxicity-with-accelerated-fractionation-radiotherapy-versus-concurrent-chemoradiotherapy-in-locally-advanced-cervical-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.114053","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}